The Effectiveness of a Coach-Focused Intervention on Preventing Knee Injuries in Amateur Football Players

August 6, 2025 updated by: Marius Henriksen

The Effectiveness of a Coach-Focused Intervention on Preventing Acute Severe Knee Injuries in Amateur Football Players: A Cluster Randomized Superiority Trial

The goal of this clinical trial is to find out if a coach-focused intervention can help prevent sudden-onset, severe knee injuries in youth and senior amateur football players. The main question it aims to answer is:

Does a coach-focused intervention reduce the number of sudden-onset, severe knee injuries? Researchers will compare a coach-focused intervention, designed to help coaches to use effective injury prevention training, to usual football practice to see if the intervention can prevent sudden-onset, severe knee injuries in football players.

Participants will:

Either receive weekly information and motivation on effective injury prevention training or continue their usual football practice for 14 weeks.

All will receive a weekly text message with a survey link to report any sudden-onset knee injuries among their players for 18 weeks.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

320

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Frederiksberg, Denmark, 2000
        • The Parker Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Coach or manager at Danish amateur football teams at levels from under 14 (U14) years to senior teams.
  2. Minimum 18 years of age.
  3. Access to a mobile phone and computer.

Exclusion Criteria:

  1. Limited Danish language skills, which prevents full understanding of the provided material and questionnaires.
  2. Affiliation to teams playing under a license ranking by the Danish Football Association where training by a physical trainer is required according to the license criteria of the Danish Football Association).
  3. Affiliation solely with old boys'/girls' teams (where the players have to be aged 32 and 29 , respectively, in the current season ).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Injury prevention training

Evidence-based injury prevention training programs and exercises will be send weekly to participants in the intervention arm.

Additionally, participants in the intervention arm will be encouraged to access a study specific online platform containing information, inspiration, pep-talks and posters on injury prevention training.

Evidence-based injury prevention training programs and exercises will be send weekly to participants in the intervention arm.

Additionally, participants in the intervention arm will be encouraged to access a study specific online platform containing information, inspiration, pep-talks and posters on injury prevention training.

Active Comparator: Usual practice
Usual training
Usual training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of acute severe knee injuries in players.
Time Frame: From baseline to end of the intervention, 14 weeks after baseline.
The difference in incidence of acute severe knee injuries (>28 time-loss days from training and matches) per 1000 hours of player exposure in players belonging to coaches in the intervention group compared with players belonging to coaches in the control group (usual practice) throughout the intervention period.
From baseline to end of the intervention, 14 weeks after baseline.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of acute knee injuries
Time Frame: From baseline to end of the intervention, 14 weeks after baseline.
The difference in incidence of all acute knee injuries (from minimal (1-3 days lost) to severe (>28 time-loss days from training or match)) per 1000 hours of player exposure in players belonging to coaches in the intervention group versus players belonging to coaches in the control group (usual practice) throughout the intervention period.
From baseline to end of the intervention, 14 weeks after baseline.
Incidence of acute minimal knee injuries
Time Frame: From baseline to end of the intervention, 14 weeks after baseline.
The difference in incidence of acute minimal knee injuries (1-3 time-loss days from training or match) per 1000 hours of player exposure in players belonging to coaches in the intervention group versus players belonging to coaches in the control group (usual practice) throughout the intervention period.
From baseline to end of the intervention, 14 weeks after baseline.
Incidence of acute mild knee injuries
Time Frame: From baseline to end of the intervention, 14 weeks after baseline.
The difference in incidence of acute mild knee injuries (4-7 time-loss days from training or match) per 1000 hours of player exposure in players belonging to coaches in the intervention group versus players belonging to coaches in the control group (usual practice) throughout the intervention period.
From baseline to end of the intervention, 14 weeks after baseline.
Incidence of acute moderate knee injuries
Time Frame: From baseline to end of the intervention, 14 weeks after baseline.
The difference in incidence of acute moderate knee injuries (8-28 time-loss days from training or match) per 1000 hours of player exposure in players belonging to coaches in the intervention group versus players belonging to coaches in the control group (usual practice) throughout the intervention period.
From baseline to end of the intervention, 14 weeks after baseline.
Time-loss days of acute knee injuries
Time Frame: From baseline to end of the intervention, 14 weeks after baseline.
The difference in burden of all acute knee injuries (the total number of time loss days from minimal (1-3 time-loss days) to severe (>28 time-loss days from training or match) per 1000 hours of player exposure in players belonging to coaches in the intervention group versus players belonging to coaches in the control group (usual practice) throughout the intervention period.
From baseline to end of the intervention, 14 weeks after baseline.
Time-loss days of acute minimal knee injuries
Time Frame: From baseline to end of the intervention, 14 weeks after baseline.
The difference in burden of acute minimal knee injuries (1-3 time-loss days from training or match) per 1000 hours of player exposure in players belonging to coaches in the intervention group versus players belonging to coaches in the control group (usual practice) throughout the intervention period.
From baseline to end of the intervention, 14 weeks after baseline.
Time-loss days of acute mild knee injuries
Time Frame: From baseline to end of the intervention, 14 weeks after baseline.
The difference in burden of acute mild knee injuries (4-7 time-loss days from training or match) per 1000 hours of player exposure in players belonging to coaches in the intervention group versus players belonging to coaches in the control group (usual practice) throughout the intervention period.
From baseline to end of the intervention, 14 weeks after baseline.
Time-loss days of acute moderate knee injuries
Time Frame: From baseline to end of the intervention, 14 weeks after baseline.
The difference in burden of acute moderate knee injuries (8-28 time-loss days from training or match) per 1000 hours of player exposure in players belonging to coaches in the intervention group versus players belonging to coaches in the control group (usual practice) throughout the intervention period.
From baseline to end of the intervention, 14 weeks after baseline.
Time-loss days of acute severe knee injuries
Time Frame: From baseline to end of the intervention, 14 weeks after baseline.
The difference in burden of acute and severe knee injuries (> 28 time-loss days from training or matches) per 1000 hours of player exposure in players belonging to coaches in the intervention group versus players belonging to coaches in the control group (usual practice) throughout the intervention period.
From baseline to end of the intervention, 14 weeks after baseline.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Elisabeth Bandak, PhD, The Parker Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2025

Primary Completion (Actual)

June 30, 2025

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

February 11, 2025

First Submitted That Met QC Criteria

February 20, 2025

First Posted (Actual)

February 25, 2025

Study Record Updates

Last Update Posted (Actual)

August 12, 2025

Last Update Submitted That Met QC Criteria

August 6, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • APPI2-MSK-2025-KNIPS_2.0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD can upon rasonable request to the investigator be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Injuries

Clinical Trials on Ahead of the Game

Subscribe